News

Announcement
Patient Story
Living Proof: Cancer Vaccine Recipients Bring Their Stories to Capitol Hill
June 4, 2026
584 results

Research Update
CD22 CAR-T Therapy Shows Results in Leukemia, Study Shows, But Could a Dual CAR-T Deliver the One-Two Punch to Avoid Relapse?
November 20, 2017
News Coverage
Seres, MD Anderson, Parker In Microbiome Immunotherapy Deal
(opens in a new tab)November 14, 2017

News Coverage
Finding a way for the ‘right’ microbiome to help cancer immunotherapy work
(opens in a new tab)November 14, 2017

News Coverage
Biotech firms race to recruit good bugs in war on cancer
(opens in a new tab)November 14, 2017
News Coverage
Parker Institute, MD Anderson and Seres developing a microbiome/PD-1/L1 combo
(opens in a new tab)November 14, 2017

Press Release
Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology
November 14, 2017

News Coverage
Sean Parker awarded SITC 2017 Public Service Award
(opens in a new tab)November 11, 2017
News Coverage
Does Gut Flora Impact the Response to Cancer Immunotherapy?
(opens in a new tab)November 7, 2017
